Concepedia

Author

Cunzhen Zhang

Second Military Medical UniversityORCID

Also Known As

Cun-Zhen Zhang, Cun-zhen Zhang, Cunzhen Zhang, Guanghui Ding

22

Publications

418

Citations

9

H-Index

13

Concepts

All Affiliations

Second Military Medical UniversityEastern Hepatobiliary Surgery HospitalShanghai Jiao Tong UniversityShanghai Institute of Nutrition and HealthChinese Academy of Sciences
CZ

About

Cunzhen Zhang is an author at Second Military Medical University specializing in immunology, radiation oncology, and surgical oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

1

1

47

2

Medicine

1

1

11

3

Environmental Engineering

1

1

47

4

Immunology

1

1

11

5

Pathology

1

1

11

Cunzhen Zhang

×

8

Publications

346

Citations

8

H-Index

YearCitations

Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis

Zhong Li, Meiling Lü, Zaili Luo,

OncoTargets and Therapy

2015

62

Fructose‐1,6‐Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis

Guijun Liu, Ningning Wang, Cunzhen Zhang,

Hepatology

2021

60

A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression

Haiyang Chen, Liang Hu, Zaili Luo,

Molecular Cancer

2015

59

Detection of 3-phenoxybenzoic acid in river water with a colloidal gold-based lateral flow immunoassay

Yuan Liu, Aihua Wu, Jing Hu,

Analytical Biochemistry

2015

47

Development and evaluation of immunoassay for zeranol in bovine urine

Yuan Liu, Cunzhen Zhang, Xiangyang Yu,

Journal of Zhejiang University SCIENCE B

2007

45

A splicing variant of Merlin promotes metastasis in hepatocellular carcinoma

Zaili Luo, Shuqun Cheng, Shi Jie,

Nature Communications

2015

37

ALDOB/KAT2A interactions epigenetically modulate TGF-β expression and T cell functions in hepatocellular carcinogenesis

Chunzhao Yin, Cunzhen Zhang, Yong‐Qiang Wang,

Hepatology

2023

25

TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reports

Haibei Xin, Cunzhen Zhang, Zhiwen Ding,

Clinics and Research in Hepatology and Gastroenterology

2021

11

Page 1